In a filing, Myriad Genetics, Inc revealed its President and CEO DIAZ PAUL J unloaded Company’s shares for reported $0.34 million on Oct 11 ’24. In the deal valued at $22.93 per share,15,000 shares were sold. As a result of this transaction, DIAZ PAUL J now holds 962,378 shares worth roughly $ 14.02 million.
Then, DIAZ PAUL J bought 15,000 shares, generating $343,950 in total proceeds.
Before that, Ancona Margaret bought 11,538 shares. Myriad Genetics, Inc shares valued at $321,019 were divested by the Officer at a price of $27.82 per share.
Craig Hallum initiated its Myriad Genetics, Inc [MYGN] rating to a Buy in a research note published on February 12, 2025; the price target was $29. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early December with a ‘”a Neutral”‘ rating. Leerink Partners also remained covering MYGN and has decreased its forecast on December 09, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Morgan Stanley started covering the stock on September 19, 2024. It rated MYGN as “an Equal-weight”.
Price Performance Review of MYGN
On Tuesday, Myriad Genetics, Inc [NASDAQ:MYGN] saw its stock jump 0.07% to $14.57. Over the last five days, the stock has gained 17.03%. Myriad Genetics, Inc shares have risen nearly 6.27% since the year began. Nevertheless, the stocks have fallen -37.76% over the past one year. While a 52-week high of $29.30 was reached on 01/10/25, a 52-week low of $12.04 was recorded on 01/23/25. SMA at 50 days reached $13.62, while 200 days put it at $21.39.
Levels Of Support And Resistance For MYGN Stock
The 24-hour chart illustrates a support level at 14.17, which if violated will result in even more drops to 13.76. On the upside, there is a resistance level at 14.94. A further resistance level may holdings at 15.30. The Relative Strength Index (RSI) on the 14-day chart is 63.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.50, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 14.39%. Stochastics %K at 85.38% indicates the stock is a selling.
The most recent change occurred on August 28, 2024 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $35 price target.
